Actual Medicinal Product (AMP) - Wezenla 45mg/0.5ml solution for injection vials (Amgen Ltd)
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Wezenla 45mg/0.5ml solution for injection vials | Start Date 18-07-2024 | End Date |
Summary
- Licensed Route
- Subcutaneous
- Availability Restrictions
- None
- Licensing Authority
- Medicines - MHRA/EMA
- EMA Indicator
- EMA Monitoring
Codes
| Code | Start Date | End Date |
|---|---|---|
| 43114211000001103 | 18-07-2024 |
Parent Products
-
VTMUstekinumab
-
VMPUstekinumab 45mg/0.5ml solution for injection v...
-
AMP(Current) Wezenla 45mg/0.5ml solution fo... (Other AMPs)
-
-
Actual Medicinal Product Pack (AMPP) Information
| Pack Size | Indicative Price | Discontinued |
|---|---|---|
| 1 vial | 214700 |